XML 13 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income (loss) $ 18,053 $ (5,116)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 49,638 37,167
Amortization of deferred financing costs 969 968
Credit loss expense   81
Deferred income tax benefit (2,696) (5,100)
Equity-based employee and director compensation expense 989 574
(Gain) loss on dispositions and lease terminations, net (33,402) 11,228
Changes in operating assets and liabilities, net of acquisitions 4,146 (5,079)
Net cash provided by operating activities 37,697 34,723
Cash flows from investing activities:    
Principal payments received on notes receivable 63 81
Proceeds from sale of assets 72,766 10,733
Capital expenditures (21,958) (11,411)
Lease termination payments to Applegreen, including inventory purchases   (25,517)
Net cash provided by (used in) investing activities 50,871 (26,114)
Cash flows from financing activities:    
Borrowings under the Credit Facility 41,000 70,013
Repayments on the Credit Facility (81,500) (36,500)
Payments of finance lease obligations (1,604) (1,513)
Payments of deferred financing costs   (74)
Distributions paid on distribution equivalent rights (146) (130)
Distributions paid on common units (39,982) (39,905)
Net cash used in financing activities (82,232) (8,109)
Net increase in cash and cash equivalents 6,336 500
Cash and cash equivalents at beginning of period 3,381 4,990
Cash and cash equivalents at end of period $ 9,717 $ 5,490